These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15371560

  • 1. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
    Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS.
    Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
    [Abstract] [Full Text] [Related]

  • 2. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
    Vlashi E, Sturgis JE, Thomas M, Low PS.
    Mol Pharm; 2009 Dec; 6(6):1868-75. PubMed ID: 19754150
    [Abstract] [Full Text] [Related]

  • 3. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.
    J Control Release; 2007 Dec 04; 124(1-2):28-34. PubMed ID: 17928088
    [Abstract] [Full Text] [Related]

  • 4. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP, Cooper SR, Hardee GE.
    Bioconjug Chem; 2003 Dec 04; 14(4):738-47. PubMed ID: 12862426
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates.
    Yang J, Chen H, Vlahov IR, Cheng JX, Low PS.
    J Pharmacol Exp Ther; 2007 May 04; 321(2):462-8. PubMed ID: 17289839
    [Abstract] [Full Text] [Related]

  • 6. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
    Reddy JA, Westrick E, Santhapuram HK, Howard SJ, Miller ML, Vetzel M, Vlahov I, Chari RV, Goldmacher VS, Leamon CP.
    Cancer Res; 2007 Jul 01; 67(13):6376-82. PubMed ID: 17616697
    [Abstract] [Full Text] [Related]

  • 7. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
    Henriksen G, Bruland OS, Larsen RH.
    Anticancer Res; 2005 Jul 01; 25(1A):9-15. PubMed ID: 15816513
    [Abstract] [Full Text] [Related]

  • 8. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E, Parker N, Wang Y, Vlahov I.
    Cancer Res; 2008 Dec 01; 68(23):9839-44. PubMed ID: 19047164
    [Abstract] [Full Text] [Related]

  • 9. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.
    Bioconjug Chem; 2008 Dec 01; 19(12):2462-70. PubMed ID: 19053298
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
    Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Müller R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W.
    Bioconjug Chem; 2003 Dec 01; 14(1):158-67. PubMed ID: 12526705
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A, Honer M, Müller C, Brühlmeier M, Müller U, Schibli R, Groehn V, Schubiger AP, Ametamey SM.
    J Nucl Med; 2006 Jul 01; 47(7):1153-60. PubMed ID: 16818950
    [Abstract] [Full Text] [Related]

  • 12. The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.
    Arote RB, Hwang SK, Lim HT, Kim TH, Jere D, Jiang HL, Kim YK, Cho MH, Cho CS.
    Biomaterials; 2010 Mar 01; 31(8):2435-45. PubMed ID: 20022105
    [Abstract] [Full Text] [Related]

  • 13. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ, Marcucci G, Lee RJ.
    Anticancer Res; 2006 Mar 01; 26(2A):1049-56. PubMed ID: 16619505
    [Abstract] [Full Text] [Related]

  • 14. Novel substrate analogs delineate an endocytotic mechanism for uptake of folate via the high-affinity, glycosylphosphatidylinositol-linked transport protein in L1210 mouse leukemia cells.
    Fan J, Kureshy N, Vitols KS, Huennekens FM.
    Oncol Res; 1995 Mar 01; 7(10-11):511-6. PubMed ID: 8866663
    [Abstract] [Full Text] [Related]

  • 15. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y, Sega E, Leamon CP, Low PS.
    Adv Drug Deliv Rev; 2004 Apr 29; 56(8):1161-76. PubMed ID: 15094213
    [Abstract] [Full Text] [Related]

  • 16. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton.
    Lewis CM, Smith AK, Kamen BA.
    Cancer Res; 1998 Jul 15; 58(14):2952-6. PubMed ID: 9679952
    [Abstract] [Full Text] [Related]

  • 17. Folate-conjugated micelles and their folate-receptor-mediated endocytosis.
    Lu T, Sun J, Chen X, Zhang P, Jing X.
    Macromol Biosci; 2009 Nov 10; 9(11):1059-68. PubMed ID: 19688723
    [Abstract] [Full Text] [Related]

  • 18. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
    Eur J Pharm Biopharm; 2008 Nov 10; 70(3):718-25. PubMed ID: 18647651
    [Abstract] [Full Text] [Related]

  • 19. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD, Theti DS, Wood N, Green M, Raynaud F, Valenti M, Forster MD, Mitchell F, Bavetsias V, Henderson E, Jackman AL.
    Cancer Res; 2005 Dec 15; 65(24):11721-8. PubMed ID: 16357184
    [Abstract] [Full Text] [Related]

  • 20. Targeting of nanoparticles: folate receptor.
    Kularatne SA, Low PS.
    Methods Mol Biol; 2010 Dec 15; 624():249-65. PubMed ID: 20217601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.